Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|March 10, 2023
Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and TreatmentsMicky K Bacchus, David S Anderson, Esther R Berko, et al.
Journal of Pediatric Hematology/Oncology|October 19, 2018
Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in NeuroblastomaNatasha Alexander, Paula Marrano, Paul Thorner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human NeuroblastomaHwan Lee, Aladdin Riad, Paul Martorano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2016
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidineKelly E Huibregtse, Kieuhoa T Vo, Steven G DuBois, et al.
Journal of Pediatric Urology|February 5, 2023
Deferring gonadectomy in patients with turner syndrome with a genetic Y component is not a safe practiceSameer Mittal, John Weaver, Aznive Aghababian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for NeuroblastomaVandana Batra, Minu Samanta, Mehran Makvandi, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pageof 3